You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 15, 2025

Details for Patent: 10,558,394


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,558,394 protect, and when does it expire?

Patent 10,558,394 protects SUBLOCADE and is included in one NDA.

This patent has forty-four patent family members in thirty-one countries.

Summary for Patent: 10,558,394
Title:Injectable flowable composition comprising buprenorphine
Abstract: The present invention is directed to a buprenorphine sustained release delivery system capable of delivering buprenorphine, a metabolite, or a prodrug thereof for a duration of about 14 days to about 3 months. The buprenorphine sustained release delivery system includes a flowable composition and a solid implant for the sustained release of buprenorphine, a metabolite, or a prodrug thereof. The implant is produced from the flowable composition. The buprenorphine sustained release delivery system provides in situ 1-month and 3-month release profiles characterized by an exceptionally high bioavailability and minimal risk of permanent tissue damage and typically no risk of muscle necrosis.
Inventor(s): Norton; Richard L. (Fort Collins, CO), Watkins; Andrew (Fort Collins, CO), Zhou; Mingxing (Fort Collins, CO)
Assignee: INDIVIOR UK LIMITED (Hull, GB)
Application Number:15/820,048
Patent Claim Types:
see list of patent claims
Composition; Compound; Device;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 10,558,394: A Detailed Analysis

Introduction

Patent 10,558,394, like any other patent, is a complex document that outlines the invention, its claims, and the scope of protection it offers. To fully comprehend this patent, it is essential to delve into its various components and the broader patent landscape.

Patent Overview

United States Patent 10,558,394 is a utility patent granted by the United States Patent and Trademark Office (USPTO). Here, we will analyze the key elements of this patent.

Patent Claims

Claim Structure

The claims section of a patent is crucial as it defines the scope of the invention. Claims are typically divided into independent and dependent claims. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims[4].

Types of Claims

  • Independent Claims: These claims define the invention broadly and are not dependent on other claims.
  • Dependent Claims: These claims narrow down the invention by adding specific limitations to the independent claims.

Claim Analysis

For Patent 10,558,394, each claim must be carefully analyzed to understand what is being protected. Here are some steps to consider:

  • Identify the Independent Claims: These claims provide the broadest definition of the invention.
  • Analyze Dependent Claims: These claims add specific details and limitations to the independent claims.
  • Determine the Scope: Understand what is included and excluded by the claims.

Patent Scope

Definition of Scope

The scope of a patent refers to the extent of protection granted by the patent claims. It is essential to understand what aspects of the invention are protected and what are not.

Practical Applications

To determine the scope, one must look at how the claims integrate abstract ideas into practical applications. For example, if a claim involves an abstract idea like a mathematical model, it must be applied in a way that improves technology or provides a practical application to be considered patent-eligible[1].

Patent Landscape

Current Trends and Updates

The patent landscape is constantly evolving, especially with updates from the USPTO. Recent guidance updates, such as the 2024 USPTO guidance on AI patent eligibility, can significantly impact how patents are evaluated.

AI and Emerging Technologies

The 2024 USPTO guidance update on AI and other emerging technologies highlights the importance of integrating judicial exceptions into practical applications. This means that claims involving AI must demonstrate concrete technological improvements to be patent-eligible[1].

Case Law and Examples

Recent case law and examples provided by the USPTO, such as Examples 47-49, offer practical guidance on how to draft claims that meet the eligibility criteria. These examples illustrate how specific applications of technologies like neural networks can meet the eligibility criteria by demonstrating improvements in computer technology[1].

Search and Analysis Tools

USPTO Resources

The USPTO provides several tools for searching and analyzing patents:

  • Patent Public Search: A web-based tool that replaces legacy search tools and offers enhanced access to prior art[4].
  • Global Dossier: A service that provides access to file histories of related applications from participating IP Offices[4].
  • Patent and Trademark Resource Centers (PTRCs): Local resources that offer training in patent search techniques[4].

International Search Resources

For a comprehensive analysis, it is also important to search international patent databases:

  • European Patent Office (EPO): Provides access to European patent databases and machine translations[4].
  • World Intellectual Property Organization (WIPO): Offers full-text search of published international patent applications and machine translations[4].

Economic and Legal Implications

Economic Impact

Patents like 10,558,394 can have significant economic implications. They can protect innovations, encourage investment, and drive technological advancement.

Legal Considerations

Understanding the legal framework is crucial. The USPTO's guidance and recent case law help ensure that patents are granted for inventions that offer concrete technological improvements and practical applications.

Real-World Applications

Practical Utility

To bolster the argument for patent eligibility, it is essential to highlight the real-world applications of the claimed method or system. Demonstrating how the abstract idea is applied in a way that provides concrete benefits or solves specific problems in the relevant field is crucial[1].

Example Analysis

For instance, if a claim involves an AI system, specifying how it is used in a real-time speech recognition system to enhance the accuracy of voice commands in hands-free environments can make the claim patent-eligible. This practical application shows how the abstract idea is transformed into a specific, practical application that provides clear benefits[1].

Key Takeaways

  • Claims Analysis: Carefully analyze the independent and dependent claims to understand the scope of the invention.
  • Practical Applications: Ensure that claims integrate abstract ideas into practical applications to meet patent eligibility criteria.
  • Current Trends: Stay updated with the latest USPTO guidance and case law, especially regarding AI and emerging technologies.
  • Search Tools: Utilize USPTO and international resources for comprehensive patent searches.
  • Economic and Legal Implications: Understand the economic and legal implications of the patent to maximize its value.

FAQs

Q: What is the importance of the claims section in a patent?

A: The claims section defines the scope of the invention and determines what is protected by the patent.

Q: How does the 2024 USPTO guidance update impact AI-related patents?

A: The update clarifies that AI-assisted inventions are evaluated on equal footing with other technologies, focusing on whether the claimed invention integrates a judicial exception into a practical application.

Q: What tools does the USPTO provide for searching and analyzing patents?

A: The USPTO offers tools like Patent Public Search, Global Dossier, and Patent and Trademark Resource Centers (PTRCs) for searching and analyzing patents.

Q: Why is it important to highlight real-world applications of a claimed invention?

A: Highlighting real-world applications demonstrates how the abstract idea is transformed into a specific, practical application, which is crucial for meeting patent eligibility criteria.

Q: How can international patent databases aid in patent analysis?

A: International patent databases, such as those from the EPO and WIPO, provide access to prior art and help in ensuring that the invention is novel and non-obvious on a global scale.

Sources

  1. Understanding the 2024 USPTO Guidance Update on AI Patent - Mintz.
  2. U.S. Patent and Trademark Office (USPTO) | USAGov - USA.gov.
  3. Patent Claims Research Dataset - USPTO - USPTO.
  4. Search for patents - USPTO - USPTO.

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 10,558,394

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Indivior SUBLOCADE buprenorphine SOLUTION, EXTENDED RELEASE;SUBCUTANEOUS 209819-001 Nov 30, 2017 RX Yes No 10,558,394 ⤷  Try for Free Y ⤷  Try for Free
Indivior SUBLOCADE buprenorphine SOLUTION, EXTENDED RELEASE;SUBCUTANEOUS 209819-002 Nov 30, 2017 RX Yes Yes 10,558,394 ⤷  Try for Free Y ⤷  Try for Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 10,558,394

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom1009549.5Jun 8, 2010

International Family Members for US Patent 10,558,394

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2011263478 ⤷  Try for Free
Brazil 112012031290 ⤷  Try for Free
Canada 2801676 ⤷  Try for Free
Chile 2012003462 ⤷  Try for Free
China 103079544 ⤷  Try for Free
Colombia 6670529 ⤷  Try for Free
Cyprus 1120761 ⤷  Try for Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.